文献速递泌尿生殖MRUS

新的前列腺癌预后分级分组(PGG):多参数MRI(mpMRI)能否准确区分低危、中危和高危癌症患者?

New prostate cancer prognostic grade group (PGG): Can multiparametric MRI (mpMRI) accurately separate patients with low-, intermediate-, and high-grade cancer?
PubMed 文献 · Abdom Radiol (NY) · 2018-01-01

该回顾性研究纳入140例根治性前列腺切除术前接受3 T mpMRI及经直肠超声引导活检的前列腺癌患者,用简单ADC指标按两级或三级系统分类并与病理分级比较。mpMRI两级系统预测准确率0.77高于三级系统0.45;mpMRI与活检联合后低估率降至1.4%、高估率降至11%。

要点

  • mpMRI两级系统(低级别PGG 1 vs 高级别PGG 2-5)预测准确率为0.77。
  • mpMRI三级系统(低级别PGG 1 vs 中级别PGG 2 vs 高级别PGG 3-5)预测准确率为0.45。
  • mpMRI与TRUS-G活检联合后低估率1.4%、高估率11%。

核心结论

  • 使用两级系统时mpMRI预测准确率高于三级系统,提示区分中级别与高级别病变可能需要更先进的指标;mpMRI与TRUS-G活检联合可降低低估和高估率,提示两种技术可能在预测肿瘤分级方面具有互补性。

研究设计与样本

  • 回顾性、符合HIPAA、经IRB批准的研究,纳入140例前列腺癌患者,根治性前列腺切除术前接受3 T mpMRI(带直肠内线圈)和经直肠超声引导(TRUS-G)活检,以根治性前列腺切除病理为参考标准。

诊断标准与关键数值

  • 两级系统:低级别/PGG 1 vs 高级别/PGG 2-5,mpMRI预测准确率0.77。
  • 三级系统:低级别/PGG 1 vs 中级别/PGG 2 vs 高级别/PGG 3-5,mpMRI预测准确率0.45。
  • mpMRI与TRUS-G活检相比根治性前列腺切除病理:低估率分别为16%和21%,高估率分别为42%和17%。
  • mpMRI与TRUS-G活检联合时:低估率1.4%,高估率11%。

临床应用与阅片要点

  • 作者认为mpMRI与TRUS-G活检联合可能在预测肿瘤分级方面具有互补性。
  • 作者认为当使用三级系统时,可能需要更先进的指标来区分中级别与高级别病变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Our objective is to determine the accuracy of multiparametric MRI (mpMRI) in predicting pathologic grade of prostate cancer (PCa) after radical prostatectomy (RP) using simple apparent diffusion coefficient metrics and, specifically, whether mpMRI can accurately separate disease into one of two risk categories (low vs. higher grade) or one of three risk categories (low, intermediate, or high grade) corresponding to the new prognostic grade group (PGG) criteria.

METHODS: This retrospective, HIPAA-compliant, IRB-approved study included 140 patients with PCa who underwent 3 T mpMRI with endorectal coil and transrectal ultrasound-guided (TRUS-G) biopsy before RP. MpMRI was used to classify lesions using a two-tier (low-grade/PGG 1 vs. high-grade/PGG 2-5) or a three-tier system (low-grade/PGG 1 vs. intermediate-grade/PGG 2 vs. high-grade/PGG 3-5). Accuracy of mpMRI was compared against RP for each system.

RESULTS: The predictive accuracy of mpMRI using the two-tier system is higher than when using three-tier system (0.77 and 0.45, respectively). There were similar rates of undergrading between mpMRI and TRUS-G biopsy compared to RP (16% & 21%; respectively); rate of overgrading was higher for mpMRI vs. TRUS-G biopsy compared to RP (42% & 17%, respectively). When mpMRI and TRUS-G biopsy are combined, rate of undergrading is 1.4% and overgrading is 11%.

CONCLUSIONS: MpMRI predictive accuracy is higher when using a two-tier vs. a three-tier system, suggesting that advanced metrics may be necessary to delineate intermediate- from high-grade disease. Rates of under- and overgrading decreased when mpMRI and TRUS-G biopsy are combined, suggesting that these techniques may be complementary in predicting tumor grade.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Holtz JN, Silverman RK, Tay KJ, et al. New prostate cancer prognostic grade group (PGG): Can multiparametric MRI (mpMRI) accurately separate patients with low-, intermediate-, and high-grade cancer? Abdom Radiol (NY). 2018. PMID: 28721479. doi:10.1007/s00261-017-1255-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。